244 related articles for article (PubMed ID: 34315901)
1. Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome.
Smith AM; LaValle TA; Shinawi M; Ramakrishnan SM; Abel HJ; Hill CA; Kirkland NM; Rettig MP; Helton NM; Heath SE; Ferraro F; Chen DY; Adak S; Semenkovich CF; Christian DL; Martin JR; Gabel HW; Miller CA; Ley TJ
Nat Commun; 2021 Jul; 12(1):4549. PubMed ID: 34315901
[TBL] [Abstract][Full Text] [Related]
2. Dnmt3a deficiency in the skin causes focal, canonical DNA hypomethylation and a cellular proliferation phenotype.
Chen DY; Ferguson IM; Braun KA; Sutton LA; Helton NM; Ramakrishnan SM; Smith AM; Miller CA; Ley TJ
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846253
[TBL] [Abstract][Full Text] [Related]
3. Remethylation of
Ketkar S; Verdoni AM; Smith AM; Bangert CV; Leight ER; Chen DY; Brune MK; Helton NM; Hoock M; George DR; Fronick C; Fulton RS; Ramakrishnan SM; Chang GS; Petti AA; Spencer DH; Miller CA; Ley TJ
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3123-3134. PubMed ID: 31996479
[TBL] [Abstract][Full Text] [Related]
4. Skeletal abnormalities in mice with Dnmt3a missense mutations.
Bell-Hensley A; Beard DC; Feeney K; Zheng H; Jiang Y; Zhang X; Liu J; Gabel H; McAlinden A
Bone; 2024 Jun; 183():117085. PubMed ID: 38522809
[TBL] [Abstract][Full Text] [Related]
5. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
[TBL] [Abstract][Full Text] [Related]
6. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response.
Scheller M; Ludwig AK; Göllner S; Rohde C; Krämer S; Stäble S; Janssen M; Müller JA; He L; Bäumer N; Arnold C; Gerß J; Schönung M; Thiede C; Niederwieser C; Niederwieser D; Serve H; Berdel WE; Thiem U; Hemmerling I; Leuschner F; Plass C; Schlesner M; Zaugg J; Milsom MD; Trumpp A; Pabst C; Lipka DB; Müller-Tidow C
Nat Cancer; 2021 May; 2(5):527-544. PubMed ID: 35122024
[TBL] [Abstract][Full Text] [Related]
7. Rapid and accurate remethylation of DNA in
Li Y; Abel HJ; Cai M; LaValle TA; Yin T; Helton NM; Smith AM; Miller CA; Ley TJ
Sci Adv; 2024 Feb; 10(5):eadk8598. PubMed ID: 38295174
[TBL] [Abstract][Full Text] [Related]
8. Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging.
Jeffries AR; Maroofian R; Salter CG; Chioza BA; Cross HE; Patton MA; Dempster E; Temple IK; Mackay DJG; Rezwan FI; Aksglaede L; Baralle D; Dabir T; Hunter MF; Kamath A; Kumar A; Newbury-Ecob R; Selicorni A; Springer A; Van Maldergem L; Varghese V; Yachelevich N; Tatton-Brown K; Mill J; Crosby AH; Baple EL
Genome Res; 2019 Jul; 29(7):1057-1066. PubMed ID: 31160375
[TBL] [Abstract][Full Text] [Related]
9. Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.
Tovy A; Rosas C; Gaikwad AS; Medrano G; Zhang L; Reyes JM; Huang YH; Arakawa T; Kurtz K; Conneely SE; Guzman AG; Aguilar R; Gao A; Chen CW; Kim JJ; Carter MT; Lasa-Aranzasti A; Valenzuela I; Van Maldergem L; Brunetti L; Hicks MJ; Marcogliese AN; Goodell MA; Rau RE
Haematologica; 2022 Apr; 107(4):887-898. PubMed ID: 34092059
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers.
Glass JL; Hassane D; Wouters BJ; Kunimoto H; Avellino R; Garrett-Bakelman FE; Guryanova OA; Bowman R; Redlich S; Intlekofer AM; Meydan C; Qin T; Fall M; Alonso A; Guzman ML; Valk PJM; Thompson CB; Levine R; Elemento O; Delwel R; Melnick A; Figueroa ME
Cancer Discov; 2017 Aug; 7(8):868-883. PubMed ID: 28408400
[TBL] [Abstract][Full Text] [Related]
11. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
[TBL] [Abstract][Full Text] [Related]
12. Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion.
Tovy A; Reyes JM; Gundry MC; Brunetti L; Lee-Six H; Petljak M; Park HJ; Guzman AG; Rosas C; Jeffries AR; Baple E; Mill J; Crosby AH; Sency V; Xin B; Machado HE; Castillo D; Weitzel JN; Li W; Stratton MR; Campbell PJ; Wang H; Sanders MA; Goodell MA
Cell Stem Cell; 2020 Aug; 27(2):326-335.e4. PubMed ID: 32673568
[TBL] [Abstract][Full Text] [Related]
13. Base-Resolution Analysis of DNA Methylation Patterns Downstream of
Duncan CG; Kondilis-Mangum HD; Grimm SA; Bushel PR; Chrysovergis K; Roberts JD; Tyson FL; Merrick BA; Wade PA
G3 (Bethesda); 2018 Mar; 8(3):805-813. PubMed ID: 29326230
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation.
Kosaki R; Terashima H; Kubota M; Kosaki K
Am J Med Genet A; 2017 Jan; 173(1):250-253. PubMed ID: 27991732
[TBL] [Abstract][Full Text] [Related]
15. Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes.
Qu Y; Lennartsson A; Gaidzik VI; Deneberg S; Karimi M; Bengtzén S; Höglund M; Bullinger L; Döhner K; Lehmann S
Epigenetics; 2014 Aug; 9(8):1108-19. PubMed ID: 24866170
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development.
Lu R; Wang P; Parton T; Zhou Y; Chrysovergis K; Rockowitz S; Chen WY; Abdel-Wahab O; Wade PA; Zheng D; Wang GG
Cancer Cell; 2016 Jul; 30(1):92-107. PubMed ID: 27344947
[TBL] [Abstract][Full Text] [Related]
17. Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
Shi X; Yang Y; Shang S; Wu S; Zhang W; Peng L; Huang T; Zhang R; Ren R; Mi J; Wang Y
BMC Cancer; 2019 Nov; 19(1):1072. PubMed ID: 31703632
[TBL] [Abstract][Full Text] [Related]
18. Mediating and maintaining methylation while minimizing mutation: Recent advances on mammalian DNA methyltransferases.
Cheng X; Blumenthal RM
Curr Opin Struct Biol; 2022 Aug; 75():102433. PubMed ID: 35914495
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic differentiation persists in human iPSCs defective in de novo DNA methylation.
Cypris O; Franzen J; Frobel J; Glück P; Kuo CC; Schmitz S; Nüchtern S; Zenke M; Wagner W
BMC Biol; 2022 Jun; 20(1):141. PubMed ID: 35705990
[TBL] [Abstract][Full Text] [Related]
20. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo.
Jeong M; Park HJ; Celik H; Ostrander EL; Reyes JM; Guzman A; Rodriguez B; Lei Y; Lee Y; Ding L; Guryanova OA; Li W; Goodell MA; Challen GA
Cell Rep; 2018 Apr; 23(1):1-10. PubMed ID: 29617651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
